Business Context and Reporting Period
This Form 8-K Current Report was filed by Blackbaud, Inc. on December 8, 2022. The filing addresses corporate governance changes, specifically the departure of two directors and the appointment of two new directors to the Board of Directors.
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on personnel changes within the Board of Directors.
Material Changes
- Director Departures: Timothy Chou, Ph.D., and Joyce M. Nelson retired from the Board on December 8, 2022. Both had served for nine years or more and were ineligible for re-nomination under Corporate Governance Guidelines. The retirements were not due to any disagreement with the Company.
- Director Appointments: Yogesh K. Gupta and Rupal S. Hollenbeck were appointed to the Board on December 8, 2022, to fill the vacancies. Both are Class A directors with terms expiring at the 2023 annual meeting.
- Independence Status: Both new directors are deemed independent, outside directors, and non-employee directors under applicable regulations.
Outlook, Risks, and Management Commentary
The filing includes biographical details for the new directors:
- Yogesh K. Gupta: Former CEO of Progress Software Corporation, Kaseya, Inc., and FatWire Software, Inc. He holds a patent in neural networks and focuses on equity and inclusion in technology.
- Rupal S. Hollenbeck: Former Chief Commercial Officer of Check Point Software Technologies, Inc., and former executive at Oracle Corporation and Intel Corporation. She is an advocate for inclusive organizations and women's professional advancement.
Compensation for the new directors will follow the Company's non-employee director practices, consisting of annual cash retainers and restricted stock grants. No related party transactions requiring disclosure were identified.
Key Facts for Investor Verification
- Verify the specific compensation amounts for non-employee directors in the Proxy Statement on Schedule 14A filed on April 19, 2022.
- Confirm the impact of the Board composition changes on committee assignments, which are not detailed in this filing.
- Note that this filing contains no financial performance data; refer to the most recent 10-K or 10-Q for financial metrics.